ABK Biomedical raises $35 million USD to bring liver cancer treatment to market
Series D funding will support commercialization of Halifax company's Eye90 microspheres. Halifax-based ABK Biomedical has raised $35 million USD ($49.1...
Series D funding will support commercialization of Halifax company's Eye90 microspheres. Halifax-based ABK Biomedical has raised $35 million USD ($49.1...
In a groundbreaking observational follow-up study, researchers led by Sundqvist and colleagues have made a significant contribution to understanding the...
Coagulation Monitoring Products MarketMarket Size and Forecast:The Global Coagulation Monitoring Products Market Size reached US$ 4.82 billion in 2024 and...
DETROIT, Oct. 13, 2025 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute, cancer centers, and other organizations nationwide recognize October...
Main findingsIn this study, based on a mean follow-up time of 5.6 years, a kidney function impairment of 25% or...
Novo Nordisk has reshaped countless waistlines. Now the Ozempic maker is aiming a little higher in the abdomen. The Danish...